South Korean medical equipment manufacturer Dentium has committed to building a third manufacturing plant, ICT VINA III, in the Danang Hi-Tech Park with an investment of US$177 million. The announcement came on November 28, as local authorities presented the investment certificate for the new facility.

This new plant will bring the total foreign direct investment (FDI) in the Danang Hi-Tech Park to approximately US$875 million, distributed across 13 projects. Dentium first entered the park in 2018 with an initial investment of US$20 million for the ICT VINA manufacturing plant, followed by the ICT VINA II plant in 2020, which was valued at US$60 million.

The company’s expansion is part of a broader effort to attract high-tech professionals both domestically and internationally, and contribute to the advancement of scientific research activities in the region. The investment is also a significant addition to Danang's strategic plan for development through 2030, as part of its "Comprehensive Development Plan for Danang Hi-Tech Park until 2030."

---